Valuation: Astec LifeSciences Limited

Market Cap 12.3B 130M 118M 109M 98.63M 186M 192M 1.31B 521M 6.57B 489M 479M 20.85B P/E 2027 *
-44.1x
P/E 2028 * 50.2x
Enterprise Value 12.3B 130M 118M 109M 98.63M 186M 192M 1.31B 521M 6.57B 489M 479M 20.85B EV / Sales 2027 *
2.2x
EV / Sales 2028 * 1.66x
Free-Float
25.9%
Yield 2027 *
0.27%
Yield 2028 * 0.23%
1 day+0.67%
1 week+5.38%
Current month+1.83%
1 month-21.80%
3 months-4.35%
6 months-26.39%
Current year-21.20%
1 week 509.6
Extreme 509.6
563.95
1 month 509.6
Extreme 509.6
728.95
Current year 509.6
Extreme 509.6
850
1 year 509.6
Extreme 509.6
941.75
3 years 509.6
Extreme 509.6
1,474.4
5 years 509.6
Extreme 509.6
2,288.8
10 years 305
Extreme 305
2,288.8
Manager TitleAgeSince
Director of Finance/CFO - 31/03/2026
Compliance Officer - 31/10/2018
Chief Operating Officer 56 30/11/2015
Director TitleAgeSince
Chairman 71 24/01/1994
Director/Board Member 56 12/04/2026
Director/Board Member 71 29/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
02/01/25 Buy 134,873 0.6877%
02/01/25 Buy

Chairman

404,782 2.0640%
02/01/25 Buy 134,954 0.6881%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+5.38%-12.81%-56.61% 130M
+0.12%+0.75%+21.98%+27.50% 33.81B
+0.14%+4.77%+47.10%+55.55% 18.3B
+0.23%-5.96%-16.56%+27.68% 17.26B
-0.87%+0.26%-3.79%-15.71% 14.64B
+0.11%-.--%-.--%-.--% 12.96B
+0.07%+1.35%+8.90%+7.60% 10.83B
-2.85%-5.00%-3.01%+147.92% 9.38B
-0.22%-.--%-.--%-.--% 8.3B
+0.62%-0.19%-24.36%+57.84% 7.15B
Average -0.21%+0.24%+1.74%+25.18% 13B
Weighted average by Cap. -0.19%+0.63%+8.71%+30.66%

Financials

2027 *2028 *
Net sales 5.6B 59.34M 53.77M 49.74M 44.88M 84.57M 87.55M 597M 237M 2.99B 223M 218M 9.49B 7.41B 78.58M 71.21M 65.86M 59.42M 112M 116M 791M 314M 3.96B 295M 289M 12.56B
Net income -279M -2.96M -2.68M -2.48M -2.24M -4.22M -4.37M -29.79M -11.81M -149M -11.1M -10.87M -473M 246M 2.61M 2.36M 2.19M 1.97M 3.72M 3.85M 26.27M 10.42M 131M 9.79M 9.58M 417M
Net Debt - -
Projected Income Statement - Annual - Astec LifeSciences Limited
Logo Astec LifeSciences Limited
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
Employees
471
Date Price Change Volume
16/11/26 ₹555.55 +0.67% 41,115
13/11/26 ₹551.85 +2.77% 105,347
12/11/26 ₹537.00 +0.45% 46,508
11/11/26 ₹534.60 +1.40% 273,400
09/11/26 ₹527.20 -7.07% 507,541
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Astec LifeSciences Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
551.85INR
Average target price
670.00INR
Spread / Average Target
+21.41%
  1. Stock Market
  2. Stocks
  3. ASTEC Stock